Windpipe procedure reduces mechanical ventilation time.
Surgically opening the windpipe, or trachea, within the first seven days of the start of mechanical ventilation decreases the time patients spend on ventilators, shortens their ICU stay and lowers their risk of ventilator-associated pneumonia, according to a systematic review published Thursday (March 11) in JAMA Otolaryngology-Head & Neck Surgery.
“We analyzed the existing medical literature to unravel a question that is very pertinent to adult critical care,” said senior author Alvaro Moreira, MD, MSc, of The University of Texas Health Science Center at San Antonio (UT Health San Antonio). “At what point should surgeons open the trachea in critical care patients to most benefit them?”
The surgery, called tracheotomy, is performed either in the operating room or at the bedside, depending on patient risk factors. The team analyzed 17 studies that included more than 3,000 patients. The systematic review compared early versus late tracheotomy, with “early” defined as being performed seven days or shorter after initiation of ventilation and “late” defined as eight days or longer, including patients who never required a tracheotomy.
Outcomes
Early tracheotomy was associated with improvement in three major clinical outcomes: ventilator-associated pneumonia (40% reduction in risk), ventilator-free days (1.7 additional days off the ventilator, on average) and ICU stay (6.3 days shorter time in unit, on average). Doing the procedure early did not impact patient mortality, however.
Patients receiving mechanical ventilation are intubated and breathe through a tube extending down into their windpipe. After 48 hours of intubation, patients in critical care units are at higher risk to develop ventilator-associated pneumonia, Dr. Moreira said.
A tracheostomy is placed for patient comfort, to wean the patient off sedatives and to increase the speed with which the patient can come off the ventilator.
“One of the hesitations for families is that their critically ill loved one is undergoing an intervention,” Dr. Moreira said. “But if the patient were to develop pneumonia, that would increase their hospital stay and, in some patients, could be deadly.
“It’s therefore a fine balance that providers and families need to consider when evaluating whether a patient is a good candidate for the intervention.”
Implications for pandemic
Although no patients in the study were COVID-positive, the findings have potential translation to hospital critical care during the pandemic.
In March 2020, a committee of the American Academy of Otolaryngology-Head & Neck Surgery advised health care workers to “avoid performing tracheotomy in COVID-19 positive or suspected patients during periods of respiratory instability or heightened ventilator dependence.” The committee said tracheotomy could be considered “in patients with stable pulmonary status but should not take place sooner than two to three weeks from the time of intubation and, preferably, with negative COVID-19 testing.”
Since that time, studies have demonstrated that tracheotomy can be safely done in a negative pressure room, with proper personal protective equipment, sedation of the patient and frequent suctioning of the site. “When investigators followed the health care providers for a month, they found that the clinicians did not contract COVID-19 when proper precautions were taken,” Dr. Moreira said.
Different professional societies now state that COVID-19 patients should be considered like other patients. However, the timing of tracheostomy placement in this population is still up for debate.
Dr. Moreira is a professor in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio. Coauthors are from the University of Pennsylvania Perelman School of Medicine and the Long School of Medicine.
Impact of Early vs. Late Tracheotomy Placement on Pneumonia and Ventilator Days in Critically Ill Patients: A Meta-Analysis
Kevin Chorath, MD; Ansel Hoang, BS; Karthik Rajasekaran, MD; Alvaro Moreira, MD, MSc
First published: March 11, 2021, JAMA Otolaryngology-Head & Neck Surgery
https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2777173
The Long School of Medicine at The University of Texas Health Science Center at San Antonio is named for Texas philanthropists Joe R. and Teresa Lozano Long. The school is the largest educator of physicians in South Texas, many of whom remain in San Antonio and the region to practice medicine. The school teaches more than 900 students and trains 800 residents each year. As a beacon of multicultural sensitivity, the school annually exceeds the national medical school average of Hispanic students enrolled. The school’s clinical practice is the largest multidisciplinary medical group in South Texas with 850 physicians in more than 100 specialties. The school has a highly productive research enterprise where world leaders in Alzheimer’s disease, diabetes, cancer, aging, heart disease, kidney disease and many other fields are translating molecular discoveries into new therapies. The Long School of Medicine is home to a National Cancer Institute-designated cancer center known for prolific clinical trials and drug development programs, as well as a world-renowned center for aging and related diseases.
The University of Texas Health Science Center at San Antonio, also referred to as UT Health San Antonio, is one of the country’s leading health sciences universities and is designated as a Hispanic-Serving Institution by the U.S. Department of Education. With missions of teaching, research, patient care and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have graduated more than 37,000 alumni who are leading change, advancing their fields, and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways “We make lives better®,” visit www.uthscsa.edu.
Stay connected with The University of Texas Health Science Center at San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.
To see how we are battling COVID-19, read inspiring stories on Impact.